Graph AI Secures $13.3M Series A Funding for Its AI-Native Patient Safety Platform
Graph AI has raised a $13.3 million Series A round led by Insight Partners, with participation from Bessemer Venture Partners. The funding will support the expansion of Graph AI's platform across North America and Europe. Founded in 2024, Graph AI aims to modernize pharmacovigilance through its AI-native patient safety system called Graph Safety. Graph Safety is designed to reduce manual workflows by leveraging intelligent software that handles operational tasks such as adverse-event report processing. The platform has already demonstrated significant improvements—reducing case turnaround time from over three hours to under 10 minutes and cutting operating costs by up to two-thirds in live deployments. It aligns with regulatory frameworks like the FDA's AI credibility assessment, EU Artificial Intelligence Act, and CIOMS guidelines. The company has launched several modules of its platform since raising a seed round last year and is preparing for additional launches this September. Investors have praised Graph AI’s ability to integrate advanced AI into patient safety operations while maintaining traceability and human oversight.
Topics: AI in healthcare patient safety pharmaceuticals venture capital